December 8, 2020. Waltham, MA. BluePrint Research Group, a leader in life sciences launch strategy, commercial analytics, and market research, has been acquired by Trinity Life Sciences, a life sciences commercialization strategic advisory, data analytics, and technology firm backed by Parthenon Capital Partners.
The BluePrint Research Group is a highly regarded player in the life sciences space and shares our commitment to solution-oriented client partnership and a superlative client experience. We will leverage our collective history to enable our clients’ success and ultimately to improve the lives of patients around the globe. We are proud to welcome their first-class team to our organization, and to continue our journey together.David Fitzhenry, CEO, Trinity